Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-22-001090
Filing Date
2022-04-04
Accepted
2022-04-04 20:22:34
Documents
1
Period of Report
2022-04-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form313392002_04042022.html 3  
1 OWNERSHIP DOCUMENT form313392002_04042022.xml 3 3201
  Complete submission text file 0000921895-22-001090.txt   4997
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2261 MARKET STREET #4307 SAN FRANCISCO CA 94114
Business Address 2261 MARKET STREET #4307 SAN FRANCISCO CA 94114 4158571965
Funicular Fund, LP (Reporting) CIK: 0001752618 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-22873 | Film No.: 22804842